Call For Paper - Upcoming Conferences

Research Article | Open Access
Volume 4 | Issue 1 | Year 2017 | Article Id. IJAC-V4I2P103 | DOI : https://doi.org/10.14445/23939133/IJAC-V4I1P102

A Study on a Novel Analytical method Development and Validation of Pharmaceutical Dosage Forms by using RP-HPLC Method

N.MD.Akram, Dr.M.Umamahesh

Citation :

N.MD.Akram, Dr.M.Umamahesh, "A Study on a Novel Analytical method Development and Validation of Pharmaceutical Dosage Forms by using RP-HPLC Method," International Journal of Applied Chemistry, vol. 4, no. 1, pp. 22-26, 2017. Crossref, https://doi.org/10.14445/23939133/IJAC-V4I1P102

Abstract

A number of pharmaceutical drugs are being introduced into the arcade every year in a cumulative phase. Some of these drugs either may be a new entity or a structural modification of existing molecular formulation in multi combination of two or more drug substances. Very often these new drugs or drug combinations are not included in the pharmacopoeias from the date of introduction into the market. This is happening due to the post phase clinical studies conducted to understand the toxicity and patient resistance which results in the introduction of a better drug by competitors. Under these conditions the standard and analytical procedures may not be presented in the official pharmacopoeias. Hence new method development for simultaneous determination and validation for such drugs has become necessary

Keywords

pharmaceutical drugs, HPLC Apparatus, Methanol.

References

1. Grempler R, Thomas L, Eckhardt M, Himmelsbach F, Sauer A, Sharp DE, Bakker RA, Mark M, Klein T, Eickelmann P. "Grazoprevir, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors". Diabetes Obes Metab, 2012, 14 (1), 83–90.
2. FDA (2015-05-15), SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood". 2015.
3. "Elbasvir Hydrochloride". The American Society of Health- System Pharmacists. Retrieved Jan 2016.
4. Hirst JA1, Farmer AJ, Ali R, Roberts NW, Stevens RJ, Quantifying the effect of Elbasvir treatment and dose on glycemic control, Diabetes Care, 2012 Feb, 35(2), 446-54.